Table 2.
Clinical parameter population summarized.
| Total Patients | PCa Patients | csPCa Patients | PZ Patients | PR3 bpMRI | csPCa PR3 bpMRI | PR3 mpMRI | csPCa PR3 mpMRI | |
|---|---|---|---|---|---|---|---|---|
| Max | 1020 | 655 | 404 | 338 | 158 | 45 | 136 | 27 |
| Min | 26 | 14 | 9 | 13 | 8 | 4 | 1 | 2 |
| Median | 151 | 104 | 65 | 78 | 49 | 11 | 21 | 10.5 |
| Total | 10,468 | 4860 | 3255 | 1349 | 1027 | 241 | 414 | 69 |
| Papers Reporting | 41 | 33 | 35 | 11 | 29 | 21 | 20 | 10 |
| Proportion Reporting | 1 | 0.8 | 0.85 | 0.27 | 0.71 | 0.51 | 0.49 | 0.24 |
PCa: prostate cancer, csPCa: clinically significant prostate cancer, PZ: peripheral zone, PR-3: PI-RADS category 3, bpMRI: biparametric MRI, mpMRI: multiparametric MRI.